Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.10.2020 | Case report

Carboplatin

Anaphylactic shock: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Zheng Y-M, et al. Successfully overcoming carboplatin hypersensitivity by continuous 48-h infusion of cisplatin plus poly (ADP-ribose) polymerase inhibitor for heavily pretreated recurrent ovarian cancer. Journal of Cancer Research and Practice 7: 134-137, No. 3, Sep 2020. Available from: URL: http://doi.org/10.4103/JCRP.JCRP_16_20 Zheng Y-M, et al. Successfully overcoming carboplatin hypersensitivity by continuous 48-h infusion of cisplatin plus poly (ADP-ribose) polymerase inhibitor for heavily pretreated recurrent ovarian cancer. Journal of Cancer Research and Practice 7: 134-137, No. 3, Sep 2020. Available from: URL: http://​doi.​org/​10.​4103/​JCRP.​JCRP_​16_​20
Metadaten
Titel
Carboplatin
Anaphylactic shock: case report
Publikationsdatum
01.10.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-85207-2

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Multiple drugs

Case report

Durvalumab

Case report

Acitretin

Case report

Nintedanib

Case report

Warfarin